Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Study of ADVM-022 in Neovascular (Wet) AMD - OPTIC Extension

NCT04645212 is registered in ClinicalTrials.gov with Adverum Biotechnologies, Inc. as lead sponsor.

NCT NCT04645212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04645212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Study of ADVM-022 in Neovascular (Wet) AMD - OPTIC Extension
Lead sponsor
Adverum Biotechnologies, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
December 14, 2020
Completion date
June 26, 2030
Enrollment
23 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age-related macular degeneration, wet age-related macular degeneration